Antibiotic resistance and consumption in community acquired respiratory tract infections (CROSBI ID 507930)
Prilog sa skupa u zborniku | sažetak izlaganja sa skupa | domaća recenzija
Podaci o odgovornosti
Matica, Biserka ; Mlinarić-Džepina, Ana ; Jarža-Davila, Neda ; Marijan, Tatjana ; Vukušić, Ivan ; Čulig, Josip
engleski
Antibiotic resistance and consumption in community acquired respiratory tract infections
Respiratory tract infections are one of the leading causes of patient attendance at doctors office(GPs).In Zagreb, respiratory tract infections (RTIs)have led to 23% of all primary care visits. S. pyogenes is still penicillin-sensitive and the macrolide resistance is 13%. Sensitivity of S. pneumoniae is good: few strains (below 1%)have developed strong resistance to penicillin (MIC veći od 32eg/ml).Resistance to macrolides is 30%. S. pneumoniae have colonised 40% of kindergarten children. The sensitivity of H. influenzae to amoksicillin is 82%. Sensitivity to all other antimicrobials is also very high. Despite viruses causing the vast majority of respiratory tract infections, the consumptions of antibacterials is very high. According to Croatian Institute for Health Insurance, anatomic group J drugs (antimicrobials for systemic use) are the leading ones prescribed. Broad-spectrum penicillins account for 90% of the main anatomic group. In 2002, Anatomical Therapeutical Chemical(ATC) drug costs represented 17% of all drug costs to our Insurance. Respiratory pathogens have a low resistance and one showing a declining trend over the last few years. The consumption of antibacterials is very high. Respiratory tract infections pose an enormous health care burden. Combating antibacterial misuse and antibiotic resistance requires antibiotic resistance surveillance, guidelines for proper use of antibiotics, and efforts to achieve a reduction in the transmission of respiratory tract pathogens. This should be one of Public Health Institutes prime responsibilities.
Antibiotics; Resistance; Consumption; Respiratory tract infections; Zagreb
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
Podaci o prilogu
92-x.
2003.
objavljeno
Podaci o matičnoj publikaciji
Book of Abstracts
Zagreb: Nastavni zavod za javno zdravstvo Dr. Andrija Štampar
Podaci o skupu
6th International Conference Health-Insurance-Transition: Biotechnology and Public Health
predavanje
09.10.2003-13.10.2003
Cavtat, Hrvatska